Evaluating for the risk of major adverse cardiovascular events within the next 1 to 5 years MI-Heart Ceramides is a blood test that measures risk for adverse cardiovascular events and quantifies plasma ceramides. Plasma ceramides are predictors of adverse cardiovascular events resulting from unstable atherosclerotic plaque.
Specimen Type
Container
Lavender Top Tube
Collection Instructions
Collection Container/Tube: Lavender top (EDTA) Specimen : 1 mL EDTA Plasma (0.5 mL min) Transport Temperature: Frozen Collection Instructions: Freeze within 8 hours. Patient Preparation: Patients should not be receiving Intralipid because it may cause false-elevations in measured ceramides
Transport Instructions
Specimen Stability
8 Hours Room Temperature 1 Day Refrigerated 30 Days frozen
Methodology
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
